window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : January 19, 2026

  • News
  • About Us
Contact Us

Digital Health

  • Clinical Development,Clinical Trials,Digital Health,Healthcare leadership,Movers & Shakers

    Qureight names Rebecca Simmons COO to lead operational scaling

    Qureight has appointed Rebecca Simmons as chief operating officer, strengthening [...]

    January 14, 2026
  • Artificial Intelligence,Clinical Trials,Data Management,Digital Health,Patient Centricity

    Nine ladies dancing: uMotif – patient-centric trials and AI take centre stage in 2026

    As part of Discover Pharma’s 12 days of Christmas series, [...]

    December 22, 2025
  • CDMOs & Manufacturing,Clinical Development,Digital Health,Market Access & Commercialization,Patient Centricity

    Seven lords a-leaping: Gifthealth CEO on why DTP must blend high tech with high touch in 2026

    For Seven lords a-leaping, Discover Pharma turns to Chip Parkinson, [...]

    December 18, 2025
  • Clinical Trials,Data Management,Digital Health,Patient Centricity

    uMotif: patient-centricity took flight again in 2025 like four calling birds

    In 2025, patient-centricity, just like the four calling birds soared [...]

    December 18, 2025
  • Digital Health

    AmeriTrust founder Peter Justen to receive healthcare innovation award at Oxford summit

    AmeriTrust Solutions founder Peter Justen will be recognised in Oxford [...]

    December 11, 2025
  • Artificial Intelligence,Clinical studies,Digital Health,Medical devices,Neurosciences

    Neuraxpharm and mjn-neuro plan launch of digital solution for early detection of epileptic seizures

    Neuraxpharm and mjn-neuro are preparing to launch a digital health [...]

    December 3, 2025
  • Digital Health,Healthcare leadership,Partnerships & Funding,Pharmaceuticals and therapeutics

    Outcome Capital launches advisory board to advance innovation in pharmacy and related services

    Outcome Capital, a life sciences and healthcare advisory and investment [...]

    November 14, 2025
  • Artificial Intelligence,Digital Health,Healthcare leadership,Partnerships & Funding

    Lightbeam Health Solutions wins 2025 Microsoft Healthcare and Life Sciences Partner of the Year

    Lightbeam Health Solutions has been named Microsoft’s 2025 Healthcare and [...]

    November 14, 2025
  • Artificial Intelligence,Partnerships & Funding,Patient Centricity,Research & Development

    Veeva and OpenEvidence form long-term AI partnership to accelerate clinical trial access and drug discovery

    Veeva Systems and OpenEvidence have announced a long-term partnership to [...]

    October 17, 2025
  • Artificial Intelligence,Clinical Trials,Digital Health,Movers & Shakers,Technology and platforms

    OptymEdge appoints senior director to lead global roll-out of ACUVERA platform

    OptymEdge has appointed Amy Del Medico as senior director of [...]

    October 6, 2025
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Veristat names Kim McLean Boericke as CEO to drive next phase of clinical research growtheristat names Kim McLean Boericke as CEO to drive next phase of clinical research growth
    Categories: Biotech, Clinical Development, Clinical studies, Clinical Trials, Healthcare leadership, Movers & Shakers, Rare Diseases
  • Will Edwards appointed CEO as Astoriom expands international storage and biorepository operations
    Categories: Biomanufacturing, CDMOs & Manufacturing, Healthcare leadership, Movers & Shakers, Pharmaceuticals and therapeutics
  • CombinAbleAI to be acquired by insitro to expand AI drug discovery platform
    Categories: Artificial Intelligence, Biotech, Drug Development, Mergers & Acquisitions, Technology and platforms
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top